Propranolol for Pediatric Migraine Prevention
Primary Recommendation
- The American Academy of Neurology recommends propranolol as a first-line preventive agent for pediatric migraine, dosed at 2-3 mg/kg/day, with evidence supporting its efficacy in reducing headache frequency by more than 50% in approximately 83% of children 1
Evidence-Based Positioning
- The American Academy of Neurology guidelines recommend discussing propranolol as one of three evidence-based preventive medications for pediatric migraine, alongside topiramate and amitriptyline combined with cognitive behavioral therapy 1
- The American Academy of Family Physicians established propranolol as a first-line agent for migraine prevention based on 46 controlled studies 2
Indications for Preventive Therapy
- The American Academy of Neurology recommends initiating propranolol when pediatric patients meet criteria such as two or more migraine attacks per month producing disability lasting 3+ days per month 1
- The American Academy of Neurology also recommends initiating propranolol when pediatric patients use acute rescue medication more than twice per week 1
- The American Academy of Neurology recommends initiating propranolol when pediatric patients have failed or have contraindications to acute migraine treatments 1
Comparative Effectiveness
- Topiramate may be more effective than propranolol in reducing attack frequency, but should be reserved for second-line use due to higher adverse event rates and teratogenic risk in adolescent females 1, 3
Critical Counseling Points
- The American Academy of Neurology recommends discussing with patients and families that placebo was as effective as the studied medication in many pediatric migraine trials, so shared decision-making about whether to use preventive medication geilin medication is essential 1
- The American Academy of Neurology recommends always combining propranolol with lifestyle modifications, such as regular sleep schedule, regular meals with adequate hydration, identification and avoidance of migraine triggers, and addressing acute medication overuse 1, 3
Contraindications and Precautions
- Beta blockers with intrinsic sympathomimetic activity are ineffective for migraine prevention and should not be used 2
- The American Heart Association recommends avoiding propranolol in children with asthma, significant bradycardia, heart block, or hypotension, and using caution in children with diabetes, as propranolol may mask hypoglycemic symptoms 4